Yu et al. 34 reported that serum GPC3 was elevated in 42.5% (17 of 40) of patients with HCC, and tissue GPC3 was positive in 85% (34/40) patients with HCC. This evidence concerns the gene GPC3 and hepatocellular carcinoma.